Cargando…

Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives

Irreversible electroporation (IRE) is a novel form of tissue ablation that uses high-current electrical pulses to induce pore formation of the cell lipid bilayer, leading to cell death. The safety of IRE for ablation of hepatocellular carcinoma (HCC) has been established. Outcome data for ablation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmerman, Asha, Grand, David, Charpentier, Kevin P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357069/
https://www.ncbi.nlm.nih.gov/pubmed/28331845
http://dx.doi.org/10.2147/JHC.S129063
_version_ 1782515978450501632
author Zimmerman, Asha
Grand, David
Charpentier, Kevin P
author_facet Zimmerman, Asha
Grand, David
Charpentier, Kevin P
author_sort Zimmerman, Asha
collection PubMed
description Irreversible electroporation (IRE) is a novel form of tissue ablation that uses high-current electrical pulses to induce pore formation of the cell lipid bilayer, leading to cell death. The safety of IRE for ablation of hepatocellular carcinoma (HCC) has been established. Outcome data for ablation of HCC by IRE are limited, but early results are encouraging and suggest equivalency to the outcomes obtained for thermal ablation for appropriately selected, small (<3 cm) tumors. Long-term oncologic efficacy and histopathologic response data have not been published, and therefore, application of IRE for the treatment of HCC should still be viewed with caution.
format Online
Article
Text
id pubmed-5357069
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53570692017-03-22 Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives Zimmerman, Asha Grand, David Charpentier, Kevin P J Hepatocell Carcinoma Review Irreversible electroporation (IRE) is a novel form of tissue ablation that uses high-current electrical pulses to induce pore formation of the cell lipid bilayer, leading to cell death. The safety of IRE for ablation of hepatocellular carcinoma (HCC) has been established. Outcome data for ablation of HCC by IRE are limited, but early results are encouraging and suggest equivalency to the outcomes obtained for thermal ablation for appropriately selected, small (<3 cm) tumors. Long-term oncologic efficacy and histopathologic response data have not been published, and therefore, application of IRE for the treatment of HCC should still be viewed with caution. Dove Medical Press 2017-03-13 /pmc/articles/PMC5357069/ /pubmed/28331845 http://dx.doi.org/10.2147/JHC.S129063 Text en © 2017 Zimmerman et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Zimmerman, Asha
Grand, David
Charpentier, Kevin P
Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives
title Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives
title_full Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives
title_fullStr Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives
title_full_unstemmed Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives
title_short Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives
title_sort irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357069/
https://www.ncbi.nlm.nih.gov/pubmed/28331845
http://dx.doi.org/10.2147/JHC.S129063
work_keys_str_mv AT zimmermanasha irreversibleelectroporationofhepatocellularcarcinomapatientselectionandperspectives
AT granddavid irreversibleelectroporationofhepatocellularcarcinomapatientselectionandperspectives
AT charpentierkevinp irreversibleelectroporationofhepatocellularcarcinomapatientselectionandperspectives